|1||Active, not recruiting||
An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies
A Study of RO5045337 in Patients With Solid Tumors
A Study of RO5045337 in Patients With Liposarcomas Prior to Debulking Surgery
A Study of RO5045337 in Combination With Doxorubicin in Patients With Soft Tissue Sarcoma
A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.
A Study of RO5045337 [RG7112] in Patients With Advanced Solid Tumors
A Study of RO5045337 in Combination With Cytarabine in Patients With Acute Myelogenous Leukemia
† Study has passed its completion date and status has not been verified in more than two years.